University of Duisburg-Essen

MSc Pharmaceutical Medicine

Practical Information

Commencing Date :
Language :
Location :
Duisburg Germany

Teaching Methodology :

European Fees :
14850 EUR
Scholarship Possibilities :

Course Contact

Gudrun Bayer-Kulla

+49 (0) 2302 - 915131


Fees Information

Office Link

University of Duisburg-Essen

University Accreditation : Yes

Centre of Excellence


In the health sector the realization of globalization of markets is already well advanced. Great effort is being made to harmonize research guidelines, require­ments for registration data and health politics. Mega mergers of pharmaceutical companies are simultaneously the result and accelerator of this development. Associated with these processes we recognize an enormous change within the institutions of the health care system and the pharmaceutical industry. In order to meet the challenges of this process in Europe it is necessary to build up an innovative education concept for peo­ple able to fulfill the demands of the future. Perceiving this situation the curriculum for the postgraduate study course Pharmaceutical Medicine was developed and after approval implemented. The objective of this study course is to focus on day-to-day practice, to promote interdisciplinary knowledge and to enable the participants to deal with the complex international tasks facing health care institutions and the pharmaceutical industry. The genaral objectives of this course are: - To give the participant an integrated overview of all relevant topics within the health institutions and the pharmaceutical industry. - To educate physicians and scientists in all major aspects of drug research and development, with emphasis on clinical development. - To stimulate an insight into the pitfalls and possibilities of research and development with a new chemical entity. - To present the health economic environment and its implications for drug development. to create an educational platform that enables the participant to fulfil and understand a variety of roles within the health institutions and the pharmaceutical industry. - To make the participant aware of various aspects of social competence as well as of the scientific, ethical and social role of the clinical scientist in professional teams within the health institutions and the pharmaceutical industry. - To train the participant in moderation and leadership of groups. - To increase the communicative skills of the candidate.

IMI Standards

  • A predefined set of teaching objectives, leading to defined learning outcomes
  • Assessment of the students' achievement in accordance with the agreed learning outcomes of the training offered
  • A system for collecting, assessing and addressing feedback from learners, teachers, technical / administrative staff and programme / course / module managers
  • Availability of appropriate and regularly reviewed reference material (e.g. published articles, links, book chapters, scripts, etc)
  • Defined and transparent admission criteria
  • Quality assurance of teaching staff
  • Regular review of the QA/QC process and demonstration that the training is further developed in light of this review
  • The facilities, infrastructure, leadership and competences available for the support of student learning
  • University accreditation OR a system for approving, monitoring and reviewing the training offered


Module Title





General Introduction to the Health System and the Pharmaceutical Industry Core No
Working in a Complex Organization Core No
Project Management Core No
Clinical Systems and Data Management Core No
Drug Discovery and Development Core No
Toxicology Core No
Biostatistics Core No
Clinical Pharmacology and Pharmacokinetics Core No
Clinical Trials I and II Core No
Managing Clinical Trials Core No
Health Economics Core No
Drug Safety Core No
Post Marketing Surveillance Core No
Regulatory Affairs Core No
Marketing and Sales Core No
Biotechnology Core No
Pharmaceutical-Related Case Studies Core No